Emergent Biosolutions reported $2.78B in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acadia Pharmaceuticals ACAD:US $ 624.25M 75.87M
Akebia Therapeutics AKBA:US $ 535.36M 9.81M
ALKERMES ALKS:US $ 1977.84M 46.64M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Amarin AMRN:US $ 973.71M 94.36M
Ani Pharmaceuticals ANIP:US $ 744.85M 26.75M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Chimerix CMRX:US $ 65.52M 35.02M
Coherus Biosciences CHRS:US $ 593.39M 85.95M
Emergent Biosolutions EBS:US $ 2780.4M 178.6M
Exact Sciences EXAS:US $ 6490.54M 194.35M
Exelixis EXEL:US $ 2654.12M 37.88M
Glaxosmithkline GSK:US $ 89689M 10586M
Heron Therapeutics HRTX:US $ 273.72M 31.98M
Immunogen IMGN:US $ 481.71M 44.06M
Intercept Pharmaceuticals ICPT:US $ 503.36M 23.67M
Ironwood Pharmaceuticals IRWD:US $ 1083.38M 43.55M
JAZZ PHA JAZZ:US $ 11768.92M 529.72M
Lexicon Pharmaceuticals LXRX:US $ 136.18M 731K
Lonza Group LONN:SW 16.46B 1.3B
Merk MRK:US $ 106668M 974M
Moderna Inc MRNA:US 27.61B 2.94B
Myriad Genetics MYGN:US $ 1255.4M 65.3M
Nektar Therapeutics NKTR:US $ 1024.12M 93.07M
Opko Health OPK:US $ 2306.86M 92.86M
Pacira Pharmaceuticals PCRX:US $ 1891.48M 183.88M
Ptc Therapeutics PTCT:US $ 1799.59M 138.46M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
Teva Pharmaceutical Industries TEVA:US $ 47059M 607M
United Therapeutics UTHR:US $ 5359.8M 190.7M
Vanda Pharmaceuticals VNDA:US $ 603.56M 9.77M
Xoma XOMA:US $ 159.16M 7.4M